Scarica l'app Stockscreener
29.46
1.54%
0.4479
Dopo l'orario di chiusura:
29.47
0.005
+0.02%
Precedente Chiudi:
$29.02
Aprire:
$29.04
Volume 24 ore:
7,531
Relative Volume:
0.65
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+6.13%
1M Prestazione:
+1.75%
6M Prestazione:
+15.32%
1 anno Prestazione:
+7.81%
Intervallo 1D:
$29.04
$29.80
Intervallo di 1 settimana:
$27.64
$29.80
Portata 52W:
$20.01
$29.80
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile
Nome
Roundhill Glp 1 Weight Loss Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta OZEM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OZEM
Roundhill Glp 1 Weight Loss Etf
|
29.46 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
331.74 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
675.24 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
678.81 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
251.12 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
619.25 | 124.43B | 0 | 0 | 0 | 0.00 |
Roundhill Glp 1 Weight Loss Etf Borsa (OZEM) Ultime notizie
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - MSN
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - Benzinga
The Investor's Guide to Buying GLP-1 Stocks - The Motley Fool
Avoiding Lag: Real-Time Signals in (OZEM) Movement - news.stocktradersdaily.com
Roundhill GLP-1 & Weight Loss ETF (NQ: OZEM - FinancialContent
Are You Making These 3 ETF Mistakes That Cost You 50% in Gains? - The Motley Fool
NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain - sg.finance.yahoo.com
Investing in the Dip: Evaluating ETF Exposure to Eli Lilly Amid Sector Volatility and GLP-1 Growth - AInvest
Will drop go up or down throughout this week - AInvest
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - ETF.com
How to Buy Ozempic Stock - The Motley Fool
Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected - The Daily Upside
HRTS: Effectively Thinning Investor Portfolios - ETF.com
ETFs to Capitalize on the Novo Nordisk-Septerna Deal - MSN
The GLP-1 Boom: Why OZEM is Poised to Capitalize on the Obesity Drug Revolution - AInvest
Inside Last Week's Wall Street Rally & Best-Performing ETF Areas - TradingView
5 Sector ETFs Up 10% Despite February's Market Slump - Nasdaq
Roundhill GLP-1 & Weight Loss ETF Review and Aggregate Rating (OZEM) - MarketBeat
Slower flows, small-cap woes, SEC nos! What to expect from ETFs in 2025 - Citywire
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Roundhill Investments Surpasses $4 Billion AUM Milestone – Company Announcement - Financial Times
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - Yahoo Finance
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
Roundhill GLP-1 & Weight Loss ETF (NASDAQ: OZEM)Dividends - intelligentinvestor.com.au
Tap the Weight-Loss Drug Market With These ETFs - Nasdaq
Ozempic and Weight Loss Drug ETFs Back in Spotlight After Key Earnings Results - Trackinsight
5 ETFs to Make the Most of Eli Lilly's Strength - Yahoo Finance
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment - Nasdaq
Where to Invest in Health Trends - Bloomberg.com
Roundhill Glp-1 & Weight Loss ETF (OZEM) Holdings - Yahoo
Novo-Nordisk's "miracle weight-loss drug" has been approved domestically, waiting to explode onto the multi-billion dollar market! How to capture this wave of "weight-loss fever"? - 富途牛牛
Why Investors Haven't Feasted on Two New Weight-Loss ETFs - Investopedia
Weight-loss ETFs demand some heavy thinking - Financial Times
Roundhill Glp-1 & Weight Loss ETF (OZEM) holdings - Yahoo
Wall Street issuer creates “Lucky 8” Chinese giant ETF to target the “Seven Heroes” of US stock technology - 富途牛牛
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk - TradingView
OZEM, Weight Loss Drug ETFs: Should You Invest? - ETF.com
OZEM: ROUNDHILL GLP-1 & WEIGHT LOSS ETFFund Chart - Zacks Investment Research
OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF - InvestorPlace
This new weight loss drug ETF bets big on two of the industry's leading players - CNBC
This Week in ETFs: Roster of 17 New ETFs Includes 6 Buffer Funds - ETF Trends
Roundhill GLP-1 & Weight Loss ETF (OZEM) Stock Holdings List - TipRanks
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next - Benzinga
Roundhill GLP-1 & Weight Loss ETF Holdings List (NASDAQ:OZEM) - MarketBeat
Roundhill GLP-1 & Weight Loss ETF ETF Price, Holdings, & News (NASDAQ:OZEM) - MarketBeat
Play These New ETFs to Tap Lucrative Weight Loss Drug Market - Yahoo Finance
OZEM Stock Fund Price and Chart — NASDAQ:OZEM - TradingView
Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM) - Stock Titan
Roundhill Glp-1 & Weight Loss ETF (OZEM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Roundhill names new CEO - Citywire
Roundhill Glp 1 Weight Loss Etf Azioni (OZEM) Dati Finanziari
Non sono disponibili dati finanziari per Roundhill Glp 1 Weight Loss Etf (OZEM). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.30%
Capitalizzazione:
|
Volume (24 ore):